Checkmate Pharmaceuticals (CMPI)
NASDAQ:CMPI
US Market
Holding CMPI?
Track your performance easily

Checkmate Pharmaceuticals (CMPI) Financial Statements

0 Followers

Checkmate Pharmaceuticals Financial Overview

Checkmate Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.919; its P/E ratio is -3.60; Checkmate Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -15.89M$ -13.35M$ -14.98M$ -18.95M$ -14.18M
EBITDA$ -15.84M$ -13.30M$ -14.98M$ -18.95M$ -14.18M
Net Income Common Stockholders$ -15.87M$ -13.34M$ -14.97M$ -18.97M$ -14.13M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 60.03M$ 70.87M$ 80.84M$ 85.35M$ 85.81M
Total Assets$ 66.94M$ 78.84M$ 89.34M$ 101.68M$ 119.71M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -60.03M$ -70.87M$ -80.84M$ -85.35M$ -85.81M
Total Liabilities$ 11.94M$ 9.38M$ 7.81M$ 6.70M$ 7.31M
Stockholders Equity$ 55.00M$ 69.46M$ 81.53M$ 94.98M$ 112.40M
Cash Flow-
Free Cash Flow$ -10.67M$ -10.16M$ -14.32M$ -15.77M$ -14.31M
Operating Cash Flow$ -10.67M$ -10.00M$ -14.02M$ -15.39M$ -14.31M
Investing Cash Flow$ -527.00K$ 6.85M$ 4.72M$ 39.36M$ 10.26M
Financing Cash Flow$ 0.00$ 326.00K$ -314.00K$ 16.00K$ 118.00K
Currency in USD

Checkmate Pharmaceuticals Earnings and Revenue History

Checkmate Pharmaceuticals Debt to Assets

Checkmate Pharmaceuticals Cash Flow

Checkmate Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis